These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 28417162)

  • 1. S100A6 protein: functional roles.
    Donato R; Sorci G; Giambanco I
    Cell Mol Life Sci; 2017 Aug; 74(15):2749-2760. PubMed ID: 28417162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins.
    Yatime L; Betzer C; Jensen RK; Mortensen S; Jensen PH; Andersen GR
    Structure; 2016 Dec; 24(12):2043-2052. PubMed ID: 27818100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
    Sung HY; Dowarha D; Chou RH; Yu C
    Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains.
    Leclerc E; Fritz G; Weibel M; Heizmann CW; Galichet A
    J Biol Chem; 2007 Oct; 282(43):31317-31. PubMed ID: 17726019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A6 Regulates Endothelial Cell Cycle Progression by Attenuating Antiproliferative Signal Transducers and Activators of Transcription 1 Signaling.
    Lerchenmüller C; Heißenberg J; Damilano F; Bezzeridis VJ; Krämer I; Bochaton-Piallat ML; Hirschberg K; Busch M; Katus HA; Peppel K; Rosenzweig A; Busch H; Boerries M; Most P
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1854-67. PubMed ID: 27386938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma.
    Li Z; Tang M; Ling B; Liu S; Zheng Y; Nie C; Yuan Z; Zhou L; Guo G; Tong A; Wei Y
    J Mol Med (Berl); 2014 Mar; 92(3):291-303. PubMed ID: 24281831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer.
    Zhang J; Zhang K; Jiang X; Zhang J
    Dig Dis Sci; 2014 Sep; 59(9):2136-44. PubMed ID: 24705642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A6 represses Calu-6 lung cancer cells growth via inhibiting cell proliferation, migration, invasion and enhancing apoptosis.
    Wang T; Han S; Du G
    Cell Biochem Funct; 2021 Aug; 39(6):771-779. PubMed ID: 34008212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubulin-dependent secretion of S100A6 and cellular signaling pathways activated by S100A6-integrin β1 interaction.
    Jurewicz E; Wyroba E; Filipek A
    Cell Signal; 2018 Jan; 42():21-29. PubMed ID: 29020611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100A6 - new facts and features.
    Leśniak W; Słomnicki ŁP; Filipek A
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1087-92. PubMed ID: 19891957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential.
    Yang F; Ma J; Zhu D; Wang Z; Li Y; He X; Zhang G; Kang X
    Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysozyme as the anti-proliferative agent to block the interaction between S100A6 and the RAGE V domain.
    Khan MI; Dowarha D; Katte R; Chou RH; Filipek A; Yu C
    PLoS One; 2019; 14(5):e0216427. PubMed ID: 31071146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the S100A6 mutant (C3S) with the V domain of the receptor for advanced glycation end products (RAGE).
    Mohan SK; Gupta AA; Yu C
    Biochem Biophys Res Commun; 2013 May; 434(2):328-33. PubMed ID: 23537648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of S100A6 gene silencing on the biological features of eutopic endometrial stromal cells and β‑catenin expression.
    Zhang X; Liu Z; Chen M; Cao Q; Huang D
    Mol Med Rep; 2017 Mar; 15(3):1279-1285. PubMed ID: 28075439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Calcium-Binding Protein S100A6 Accelerates Human Osteosarcoma Growth by Promoting Cell Proliferation and Inhibiting Osteogenic Differentiation.
    Li Y; Wagner ER; Yan Z; Wang Z; Luther G; Jiang W; Ye J; Wei Q; Wang J; Zhao L; Lu S; Wang X; Mohammed MK; Tang S; Liu H; Fan J; Zhang F; Zou Y; Song D; Liao J; Haydon RC; Luu HH; He TC
    Cell Physiol Biochem; 2015; 37(6):2375-92. PubMed ID: 26646427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A6 is secreted from Wharton's jelly mesenchymal stem cells and interacts with integrin β1.
    Jurewicz E; Góral A; Filipek A
    Int J Biochem Cell Biol; 2014 Oct; 55():298-303. PubMed ID: 25256682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line.
    Chen X; Liu X; Lang H; Zhang S; Luo Y; Zhang J
    PLoS One; 2015; 10(3):e0121319. PubMed ID: 25799022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A6 - focus on recent developments.
    Leśniak W; Wilanowski T; Filipek A
    Biol Chem; 2017 Sep; 398(10):1087-1094. PubMed ID: 28343163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A6 (calcyclin) deficiency induces senescence-like changes in cell cycle, morphology and functional characteristics of mouse NIH 3T3 fibroblasts.
    Słomnicki LP; Leśniak W
    J Cell Biochem; 2010 Feb; 109(3):576-84. PubMed ID: 20013795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.